News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
89bio
NEWS
JOBS
IN THE PRESS
555 Montgomery Street, Suite 1500
San Francisco, CA 94111
Tel: (415) 432-9270
Visit website
Email Us
NEWS
Drug Development
Clinical Catch-Up: August 2-6
It was a busy week for clinical trial announcements. Take a look.
August 6, 2021
·
7 min read
·
Mark Terry
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
·
5 min read
Press Releases
89bio Provides Business Update and Outlook for 2025
January 14, 2025
·
5 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 19, 2024
December 20, 2024
·
1 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 29, 2024
December 1, 2024
·
1 min read
Press Releases
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
November 15, 2024
·
7 min read
Press Releases
89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
November 13, 2024
·
4 min read
Press Releases
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
November 12, 2024
·
5 min read
Press Releases
89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
November 8, 2024
·
9 min read
Press Releases
89bio to Participate in the UBS Global Healthcare Conference
November 6, 2024
·
1 min read
Press Releases
89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024
October 16, 2024
·
8 min read